Delivery Order SPE2DR25D1100-SPE2DR26FCT2Y
Award Date 12/5/25
Potential Completion Date 12/29/25
Potential Value $2.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Hemangeol 4.28 mg/ml oral solution (120ml) with a contract value of $2,662.56 and a firm fixed price structure. The order is set to be completed by December 22, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $10,106.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Hemangeol 4.28 mg/mL oral solution (120 mL) on August 29, 2025, with completion targeted for September 22, 2025. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to the company's corporate office location in...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The order is for the pharmaceutical product HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, with a ceiling value of $1,656.80 and a period of performance through May 21, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,656.80 firm fixed price contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a completion date of May 8, 2024 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a potential value of $1,242.60 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award. The contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,656.80 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit company Cencora, Inc. doing business as Amerisourcebergen. The contract is for the delivery of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a completion date of March 26, 2024. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product. The contract has a ceiling value of $1,684.36 and is a Firm Fixed Price arrangement. The period of performance extends to July 16, 2025. This appears to be an order under a larger Indefinite Delivery Contract (IDC) held by...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $49,771.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside competitive award is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Hemlibra 105 mg/0.7 mL vials with a ceiling value of $24,673.08 under a firm fixed-price contract structure. This delivery order, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award is executed as a child contract under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,179.22 to AmerisourceBergen Drug Corp on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, issued as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's broader relationship with the Defense Logistics Agency (DLA). The award is structured as a delivery order, indicating it derives from an existing indefinite...